<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03196934</url>
  </required_header>
  <id_info>
    <org_study_id>MulticareHSRI</org_study_id>
    <nct_id>NCT03196934</nct_id>
  </id_info>
  <brief_title>Expanded Use of Cannabidiol Oral Solution</brief_title>
  <official_title>A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steven Phillips</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MultiCare Health System Research Institute</source>
  <brief_summary>
    <textblock>
      To allow subjects who have completed Insys 030 extension study to continue to take
      Cannabidiol oral solution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To allow subjects who have completed Insys 030 extension study (A multicenter, open-label,
      flexible dose study to assess the long-term safety of pharmaceutical Cannabidiol Oral
      Solution as an adjunctive treatment for pediatric subjects with a treatment-resistant seizure
      disorder who complete INS011-14-029 or Part A of INS011-15-054) to continue to take
      Cannabidiol oral solution.
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <expanded_access_info>
    <expanded_access_type_intermediate>Yes</expanded_access_type_intermediate>
  </expanded_access_info>
  <condition>Refractory Epilepsy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cannabidiol oral solution</intervention_name>
    <description>Cannabidiol; Pharmacological class of drug</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Completed the Insys 030 protocol

          2. Compliant in drug study procedures

          3. Non-pregnant females of child bearing age, willing to utilize a double-barrier method
             of birth control during treatment and for 30 days after treatment has ended

        Exclusion Criteria:

          1. Failure to follow study procedures in Insys 030

          2. Pregnant females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Stacie Rebar</last_name>
    <phone>253-403-7251</phone>
    <email>stacie.rebar@multicare.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cassidy Canorro</last_name>
    <phone>253-403-9348</phone>
    <email>cassidy.canorro@multicare.org</email>
  </overall_contact_backup>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>MultiCare Health System Research Institute</investigator_affiliation>
    <investigator_full_name>Steven Phillips</investigator_full_name>
    <investigator_title>Pediatric Neurologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

